Home
HelpTest ID IBDP2 Inflammatory Bowel Disease Serology Panel, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL Serum
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Reporting Name
Inflammatory Bowel Disease Panel, SSpecimen Type
SerumSpecimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 21 days |
| Frozen | 21 days |
Report Available
3 to 7 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| IBDP2 | Inflammatory Bowel Disease Panel, S | 87551-8 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 610030 | Cytoplasmic Neutrophilic Ab IBD, S | 17355-9 |
| SCERA | Saccharomyces cerevisiae Ab, IgA, S | 47320-7 |
| SCERG | Saccharomyces cerevisiae Ab, IgG, S | 47321-5 |
| 614542 | ANCA2 Interpretation | 49308-0 |
Forms
If not ordering electronically, complete, print, and send Gastroenterology and Hepatology Test Request (T728) with the specimen.
Useful For
Distinguishing between ulcerative colitis and Crohn disease in patients for whom the specific diagnosis is unclear based on endoscopic, pathologic, and imaging evaluations
This test is not useful for determining the extent of disease in patients with inflammatory bowel disease or determining the response to disease-specific therapy including surgical resection of diseased intestine.
Day(s) Performed
Monday through Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
86671 x 2
86036
Specimen Minimum Volume
Serum: 0.8 mL
Reference Values
CYTOPLASMIC NEUTROPHIL ANTIBODIES, INFLAMMATORY BOWEL DISEASE PANEL, SERUM
Negative (not detectable)
SACCHAROMYCES CEREVISIAE ANTIBODY, IGA
Negative: <20.0 RU/mL
Positive: ≥20.0 RU/mL
SACCHAROMYCES CEREVISIAE ANTIBODY, IGG
Negative: <20.0 RU/mL
Positive: ≥20.0 RU/mL
Method Name
ANCA2: Indirect Immunofluorescent Assay (IFA)
SCERA, SCERG: Enzyme-Linked Immunosorbent Assay (ELISA)
Profile Information
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| ANCA2 | Cytoplasmic Neutrophilic Ab IBD, S | No | Yes |
| SCERA | Saccharomyces cerevisiae Ab, IgA, S | Yes | Yes |
| SCERG | Saccharomyces cerevisiae Ab, IgG, S | Yes | Yes |
Testing Algorithm
For more information see the following:
-Inflammatory Bowel Disease Diagnostic Testing Algorithm
-Ulcerative Colitis and Crohn Disease Therapeutic Drug Monitoring Algorithm